SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom D who wrote (266)12/4/1997 1:00:00 PM
From: scott harrison  Read Replies (1) of 887
 
Ok Tom: Humor a few stupid questions. If Depo is similar to Anesta, then it's approaching the ODAC meeting. Anesta ran up in the 20's before the meeting, got unanimous approval, ran to 29 in after-hours, then settled at 26. In the next month before the FDA approval decision, the stock dropped to the teens on black monday, and lay at 22 before the decision date. Now I'd love for DEPO to run up like Anesta, but would it be wise to sell on the 19th, and perhaps buy back in when the stock settles? Your thoughts. All this, of course, is assuming ODAC sends them on their way with smiles on their faces. (and ours). scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News